LivaNova LIVN
NASDAQ LIVN
$78.02 -2.82 (-3.49%)
At close: Aug 20, 2026 · 1:39 PM UTC

LivaNova (LIVN) Cash from Investing Activities (2015 - 2026)

LivaNova (LIVN) posted Cash from Investing Activities of -$14.6 million for Q1 2026, up 51.82% sequentially from -$30.3 million in Q4 2025, and down 37.18% YoY from -$23.2 million in Q1 2025.

LivaNova (LIVN) Cash from Investing Activities (2015 - 2026) Analysis & Trends

LivaNova has reported Cash from Investing Activities for 12 years, with the latest figure at -$14.6 million in Q1 2026.

  • Quarterly Cash from Investing Activities fell 37.18% year-over-year to -$14.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$76.9 million (down 46.62% YoY) and the FY2025 annual result came in at -$72.9 million, down 51.4% from the prior year.
  • Cash from Investing Activities grew to -$14.6 million in Q1 2026 per LIVN's latest filing, from -$30.3 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$5.5 million in Q1 2022 and troughed at -$30.3 million in Q4 2025.
  • A 5-year average of -$12.6 million and a median of -$11.0 million in 2022 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities slumped 201.65% in 2022, then soared 58.79% in 2023.
  • Over 5 years, Cash from Investing Activities stood at -$11.0 million in 2022, then slipped by 10.82% to -$12.1 million in 2023, then advanced by 11.78% to -$10.7 million in 2024, then slumped by 182.58% to -$30.3 million in 2025, then soared by 51.82% to -$14.6 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$14.6 million, -$30.3 million, and -$23.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 198.91 Bn 193.31 Bn 7.27 Bn -673.00 Mn
2 Stryker 127.59 Bn 124.11 Bn 4.50 Bn -639.00 Mn
3 Medtronic 118.77 Bn 109.55 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 73.24 Bn 72.70 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn -193.20 Mn
6 Dexcom 34.38 Bn 32.44 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.96 Bn 31.85 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn -22.08 Mn
9 Steris 23.08 Bn 22.60 Bn 684.20 Mn -108.50 Mn
10 LivaNova 4.29 Bn 3.77 Bn 273.67 Mn -31.92 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -31.92 Mn
Jun 30, 2026 -31.92 Mn
Mar 31, 2026 -14.58 Mn
Mar 31, 2026 -14.58 Mn
Dec 31, 2025 -30.26 Mn
Dec 31, 2025 -30.26 Mn
Sep 30, 2025 -23.06 Mn
Sep 30, 2025 -23.06 Mn
Jun 30, 2025 -8.97 Mn
Jun 30, 2025 -8.97 Mn
Mar 31, 2025 -10.63 Mn
Mar 31, 2025 -10.63 Mn
Dec 31, 2024 -10.71 Mn
Dec 31, 2024 -10.71 Mn
Sep 30, 2024 -18.52 Mn
Sep 30, 2024 -18.52 Mn
Jun 30, 2024 -12.57 Mn
Jun 30, 2024 -12.57 Mn
Mar 31, 2024 -6.36 Mn
Mar 31, 2024 -6.36 Mn